Systemic approach to improving treatment outcome in nasopharyngeal carcinoma: current and future directions
- PMID: 18498420
- PMCID: PMC11158701
- DOI: 10.1111/j.1349-7006.2008.00836.x
Systemic approach to improving treatment outcome in nasopharyngeal carcinoma: current and future directions
Abstract
Systemic therapy is an integral part of the management of non-keratinizing nasopharyngeal carcinoma (NPC). The purposes of this review are to provide the latest results and future directions of clinical and translational research for this disease, and to illustrate how some of these new therapies have improved the treatment outcome for patients with NPC. Particular attention will be paid to the clinical application of chemotherapy in the adjunctive treatment of locoregionally advanced NPC, novel targeted drugs, Epstein-Barr virus-targeted vaccine therapies, and the use of plasma Epstein-Barr virus DNA as a biomarker for selecting patients for adjunctive therapies.
Similar articles
-
Novel therapy for nasopharyngeal carcinoma--where are we.Oral Oncol. 2014 Sep;50(9):798-801. doi: 10.1016/j.oraloncology.2014.01.002. Epub 2014 Jan 22. Oral Oncol. 2014. PMID: 24462373 Review.
-
Advances in systemic treatment for nasopharyngeal carcinoma.Chin Clin Oncol. 2016 Apr;5(2):21. doi: 10.21037/cco.2016.03.03. Chin Clin Oncol. 2016. PMID: 27121881 Review.
-
Epstein-Barr virus-specific adoptive immunotherapy for recurrent, metastatic nasopharyngeal carcinoma.Cancer. 2017 Jul 15;123(14):2642-2650. doi: 10.1002/cncr.30541. Epub 2017 Feb 21. Cancer. 2017. PMID: 28222215 Clinical Trial.
-
Systemic treatment strategies and therapeutic monitoring for advanced nasopharyngeal carcinoma.Expert Rev Anticancer Ther. 2006 Mar;6(3):383-94. doi: 10.1586/14737140.6.3.383. Expert Rev Anticancer Ther. 2006. PMID: 16503855 Review.
-
Five-year disease-free survival of Epstein-Barr virus-associated locoregionally advanced undifferentiated nasopharyngeal carcinoma patients treated with chemo-radiotherapy: a case report.Ann Palliat Med. 2022 Mar;11(3):1147-1152. doi: 10.21037/apm-22-168. Ann Palliat Med. 2022. PMID: 35365045
Cited by
-
Co-expression of PD-1 and PD-L1 predicts poor outcome in nasopharyngeal carcinoma.Med Oncol. 2015 Mar;32(3):86. doi: 10.1007/s12032-015-0501-6. Epub 2015 Feb 22. Med Oncol. 2015. PMID: 25702326
-
Prognostic value of early radiological response to first-line platinum-containing chemotherapy in patients with metastatic nasopharyngeal carcinoma.Cancer Med. 2020 Feb;9(3):920-930. doi: 10.1002/cam4.2751. Epub 2019 Dec 13. Cancer Med. 2020. PMID: 31834990 Free PMC article.
-
Outcomes of Saudi Arabian Patients With Nasopharyngeal Cancer Treated With Primarily Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiotherapy.J Glob Oncol. 2016 Feb 3;2(3):123-128. doi: 10.1200/JGO.2015.001743. eCollection 2016 Jun. J Glob Oncol. 2016. PMID: 28717691 Free PMC article.
-
Preclinical evaluation of sunitinib as single agent or in combination with chemotherapy in nasopharyngeal carcinoma.Invest New Drugs. 2011 Dec;29(6):1123-31. doi: 10.1007/s10637-010-9451-1. Epub 2010 May 15. Invest New Drugs. 2011. PMID: 20467883
-
Expression of programmed death ligand-1 predicts poor outcome in nasopharyngeal carcinoma.Mol Clin Oncol. 2017 Sep;7(3):378-382. doi: 10.3892/mco.2017.1318. Epub 2017 Jul 13. Mol Clin Oncol. 2017. PMID: 28781814 Free PMC article.
References
-
- Law CK, Mang O. Cancer incidence in Hong Kong. Med Bull 2007; 12: 18–21.
-
- Lee AW, Sze WM, Au JS et al . Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experience. Int J Radiat Oncol Biol Phys 2005; 61: 1107–16. - PubMed
-
- Hui EP, Leung SF, Au JS et al . Lung metastasis alone in nasopharyngeal carcinoma: a relatively favorable prognostic group. A study by the Hong Kong Nasopharyngeal Carcinoma Study Group. Cancer 2004; 101: 300–6. - PubMed
-
- Baujat B, Bourhis J, Chan AT et al . Chemotherapy in locally advanced nasopharyngeal carcinoma: An individual patient data meta‐analysis of eight randomized trials and 1753 patients. Int J Radiat Oncol Biol Phys 2006; 64: 47–56. - PubMed
-
- Huncharek M, Kupelnick B. Combined chemoradiation versus radiation therapy alone in locally advanced nasopharyngeal carcinoma: results of a meta‐analysis of 1528 patients from six randomized trials. Am J Clin Oncol 2002; 25: 219–23. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical